Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression
about
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cellsThe Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activationThe oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cellsLatent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathwayInterferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuitActivation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane proteinThe viral etiology of AIDS-associated malignanciesBiology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue.Epstein-Barr virus latent genesTRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1Lupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-κB activationEpstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.Simian homologues of human herpesvirus 8Signaling activities of gammaherpesvirus membrane proteinsAn Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationEpstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promotersLinkage between STAT regulation and Epstein-Barr virus gene expression in tumors.Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic miceEpstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphomaEvolutionary aspects of oncogenic herpesvirusesThe expression and function of Epstein-Barr virus encoded latent genesMaintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell linesEpstein-barr virus-induced changes in B-lymphocyte gene expression.Virus and cell RNAs expressed during Epstein-Barr virus replicationIL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display.LMP1 strain variants: biological and molecular properties.Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaBEpstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway ActivationChanges in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders.
P2860
Q22254088-1EB3760A-67B7-47BC-835E-4CDCDB5AB113Q24554457-26D63E81-DD29-4D29-9E3D-FCC4307A3505Q24674848-2290E3BC-6729-483B-BD8D-6D158E9CE131Q24675683-D72F8885-51DB-4812-90C4-DB4E1D045604Q24682515-B35F171F-531D-4415-AB5D-3ED73AE424BAQ24683031-63BA6D80-0A75-485C-91AB-3EA6DD2A631FQ24683297-FB3B4537-602B-494E-AC33-C6C02B6BB13AQ24685892-617EEC53-ED18-4215-9730-3508D284689BQ24796992-B16F0C2F-D6E5-44A8-89C3-A177F4433485Q24806909-D70127C0-D83E-4E8D-9230-9498DE2E4CB3Q28082701-4D87927D-A6E4-4B26-8AD1-4D55BB80E420Q28361340-0CDBB2FB-0683-47C8-9E1A-84A2DF38FD4BQ28535439-8D2F727F-04A6-49F4-9737-8357FB76D0F8Q30941129-3E4F7DE4-428D-47E8-A07D-9A4EB3A2534AQ33772240-51C94C66-7CAF-4932-9129-F012F7BC7E16Q33822504-EE29FA5A-DC96-4D4F-AD14-2E5389EF9152Q33825713-DC9EE17F-103B-4F68-8443-DAE29348A723Q33843054-14E3B1BF-ACF2-4AF2-8FA7-A37E1F20A620Q33845947-E33CF3AC-CB44-45BF-8438-00C22A6788D2Q33866046-17F654A8-3765-4106-82EF-D5B8A5C0206FQ33870488-D6F13F3D-4FE7-432F-AEDA-DEB58E5A135CQ33943771-A67B71B7-5644-4E0F-8387-B196A7FB645CQ34023761-4670E473-2441-476F-AE7C-A99BDDC65057Q34089478-F05F7139-C37B-46FF-9E55-96A9DC94CEC5Q34089485-7ECA71BE-F56D-4667-A32C-6C5797A34791Q34107917-619B4684-AD99-4216-9238-2C4021E016A8Q34327176-B2B36942-E135-40A4-A2DB-B7E0FA29AD04Q34347958-3265D7F6-C836-47F8-880C-DB239370FD9FQ34434702-93552B60-8DBF-4E77-96BC-85D60FECCEE3Q34479733-D30841C6-0FB4-4311-B85C-86166F945092Q34532370-FB3CB550-160A-4B28-BA64-B5E4828F8DB5Q34682093-FE03A004-47B1-48C4-8491-74FFB4DDC9DAQ34717145-8413829E-A0CD-4F4A-AD32-356924A45164Q35121711-9728F83C-655B-4111-BDE7-FEB63FB7C224Q35122447-F1D551F6-ACB9-46BF-B604-08921353AD6BQ35139273-D2064AA7-E50D-439F-9FF6-14984DD82DDDQ35291650-6711110A-67F8-4696-B6FA-7A3A046CD7A4Q35634395-A8935659-E5B9-42EC-B890-2A2C448E9B47Q35677629-9BF2764C-D3B7-4DC9-B619-EE1B4A840D20Q35680531-186E1F1D-94EB-47D8-AF17-017E20E64134
P2860
Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Role of the TRAF binding site ...... 1-induced cell gene expression
@ast
Role of the TRAF binding site ...... 1-induced cell gene expression
@en
type
label
Role of the TRAF binding site ...... 1-induced cell gene expression
@ast
Role of the TRAF binding site ...... 1-induced cell gene expression
@en
prefLabel
Role of the TRAF binding site ...... 1-induced cell gene expression
@ast
Role of the TRAF binding site ...... 1-induced cell gene expression
@en
P2093
P2860
P1433
P1476
Role of the TRAF binding site ...... 1-induced cell gene expression
@en
P2093
E D Cahir McFarland
G Mosialos
O Devergne
P2860
P304
P577
1998-10-01T00:00:00Z